Preclinical discovery for R&D is slow, costly, and outdated
R&D Focus
Ai assisted biotech platform
Innovative Solution
Nemalife is developing an AI-assisted platform accelerating the value chain from early-phase discovery to the assessment of product potency and health claims
Solution Effectiveness
Nemalife reduces the cost and carbon footprint associated with screening, performing human-relevant high throughput biology
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
$2.25M
Last Funding Amount
$1M
Startup Stage
Early Stage
Lead Investors
National Institute of Aging (NIA), Motif FoodWorks, National Institutes of Health, TTU Accelerator
People
Founders
Siva Vanapalli Ph.D
Mizanur Rahman
Nicki Vanapalli
CEO
Siva Vanapalli
Products
Demo Product or Complete Product?
Development
Awards and Recognitions
Media Apperance
Nature, Nutraingredients
M&A and Collabs
Collab
NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in David E. Olson’s Lab
